How does treatment differ for a single vs multiple brain metastases?

The number of lesions is one of the biggest factors in the plan. For a single (solitary) brain metastasis, options often include focused stereotactic radiosurgery or coordinated surgery to remove a large or symptomatic lesion, sometimes followed by radiosurgery to the surgical cavity. For a limited number of lesions (often up to about ten), radiosurgery treats each spot individually while sparing healthy brain. When there are many lesions or leptomeningeal spread, whole-brain radiation may be preferred. In every case, your systemic therapy for the primary cancer continues, and a tumour board — not a single specialist — decides the mix.

What is a solitary brain metastasis and does it change the outlook?

A solitary brain metastasis is a single metastatic lesion in the brain — and it is important to check whether it is truly the only site of cancer, or whether the brain is one of several affected areas (that distinction, sometimes called "solitary" versus "single", changes the plan). A genuinely single lesion often allows the most focused, aggressive local treatment — radiosurgery or coordinated surgery — which can give durable control. Published series suggest outcomes are generally more favourable with fewer lesions, better performance status, and a well-controlled primary cancer. Any number quoted should be a range framed for your specific case, attributed to guidelines such as NCCN or EANO, never a guarantee.

How many brain metastases can be treated with radiosurgery instead of whole-brain radiation?

There is no single fixed cut-off. Historically, radiosurgery was used for one to a few lesions, but modern NCCN and EANO guidance supports treating a limited number of metastases — and many centres now treat ten or more — with focused radiosurgery rather than irradiating the whole brain. The decision weighs the total volume of disease as much as the raw count, plus lesion size, your performance status, and how well the primary cancer is controlled. Radiosurgery is favoured where feasible because it preserves memory and thinking far better than whole-brain radiation. A tumour board reviews the MRI to decide what is realistic for you.

When is whole-brain radiation still the better choice for multiple brain mets?

Whole-brain radiation still has a clear role. It is often preferred when there are numerous lesions beyond what radiosurgery can practically cover, when there is leptomeningeal (lining) spread, or when disease is progressing rapidly. When whole-brain radiation is needed, modern planning can use hippocampal-avoidance techniques and protective medication to reduce the memory and cognitive side effects historically linked to it. The trade-off between covering all disease and protecting cognition is exactly the kind of decision a multidisciplinary brain metastases tumour board is designed to weigh. A second opinion is reasonable if whole-brain radiation was offered without discussing radiosurgery.

Does the type of primary cancer change the plan for single vs multiple mets?

Yes — significantly. The brain lesions are still the original cancer type, so the molecular profile of the primary drives the systemic plan alongside brain-directed treatment. Some lung cancers respond to brain-penetrant targeted drugs; breast cancer is treated by hormone-receptor and HER2 status; melanoma and kidney cancer brain metastases can respond to immunotherapy. When effective systemic therapy is available, even multiple lesions may be controlled with a combination of focused local treatment and drugs — which can shift the balance away from whole-brain radiation. That is why CION coordinates the brain plan with the oncologist managing the primary cancer.

Does CION perform brain surgery for a single metastasis in-house?

CION delivers radiation therapy (including coordinated radiosurgery), systemic and medical therapy, imaging, molecular testing, steroid and seizure management, and supportive and rehabilitation care directly. When neurosurgery is needed — for example, removing a large single lesion causing pressure, or obtaining tissue when the primary is unknown — it is coordinated with accredited neurosurgical partners, while CION manages the overall plan and the radiation and systemic treatment that follow. This gives you one joined-up plan across the team rather than fragmented care, whether you have a single lesion or several.

When should I get a second opinion about single vs multiple brain mets?

A second opinion is especially worthwhile if whole-brain radiation was recommended without discussing radiosurgery for a limited number of lesions; if your systemic treatment was not updated based on current molecular or receptor testing of the primary; or if you were told nothing more can be done before a multidisciplinary tumour board reviewed your MRI. The single-versus-multiple decision has shifted rapidly as radiosurgery has expanded to treat more lesions. CION offers a free written second opinion — bring your brain MRI, pathology and prior treatment records. Request a review here.